Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on July 8, 2025
ScribeRyte AI Medical Scribing Solutions to be Presented at HIMSS AI in Healthcare Forum
EIN Presswire
·
July 8, 2025
BROOKLYN, NY, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- ScribeEMR, a leading provider of AI-powered healthcare documentation solutions, will demo its ScribeRyte AI advanced medical charting platform during the HIMSS AI in Healthcare Forum, July …
Captive or Custom Designed In-House Financing Enables Product Manufacturers and Emerging Technologies to Improve Sales
EIN Presswire
·
July 8, 2025
In-house financing is an excellent differentiator, competitive advantage, and sales tool for mature product manufacturers as well as emerging tech companies RYE BROOK, NY, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- In a rapidly evolving …
Alliance Animal Health Named an Inc.’s Best Workplace 2025
EIN Presswire
·
July 8, 2025
Nationally honored for building a culture where people feel supported, empowered, and proud to grow. RYE BROOK, NY, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- Alliance Animal Health is proud to be named one of Inc. Magazine’s Best Workplaces of …
New Campaign Supports Early-Career Parkinson Researchers
EIN Presswire
·
July 8, 2025
Fuel the Future of Parkinson Science campaign supports early-career Parkinson researchers by providing travel grants to attend the 7th World Parkinson Congress. NEW YORK, NY, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- The "Fuel the Future of …
Promising New Data Shows Cellular Therapy Treatment from NeuroGenesis Significantly Improves Lifespan for ALS Patients
EIN Presswire
·
July 8, 2025
NeuroGenesis reveals positive survival outcomes in patients with ALS treated with “NG01”, a novel cell therapy in a new publication. ROCHESTER, NY, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- A groundbreaking study published in the Journal of …
Mother Goose Health and Mamaya Health Partner to Expand Personalized Mental Health Support for Expecting and New Mothers
EIN Presswire
·
July 8, 2025
Mamaya Health brings culturally responsive, flexible mental health care to strengthen Mother Goose’s whole-person maternal care model. NEW YORK, NY, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- Mother Goose Health, a digital platform delivering …
Ardmore Institute of Health Supports The Institute for Functional Medicine in Helping Clinicians Address Chronic Disease
GlobeNewswire
·
July 8, 2025
Washington State, USA, July 08, 2025 (GLOBE NEWSWIRE) -- FEDERAL WAY, Wash. – July 8, 2025 – The Institute for Functional Medicine (IFM) today announced that Ardmore Institute of Health (AIH) has awarded it a $30,000 grant to accelerate the adoption of …
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
GlobeNewswire
·
July 8, 2025
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases …
AJA Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
July 8, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts
GlobeNewswire
·
July 8, 2025
GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for …
Vireo Growth Inc. Completes Loan Refinancing and Upsize With a Bank Led Syndicate Arranged by CEO, John Mazarakis
GlobeNewswire
·
July 8, 2025
-- Company completes refinancing of all existing senior secured debt through a $120 million self-syndicated term loan with leading banks, at an interest rate of 8.3% -- -- Company also complies expansion of its consolidated credit facilities with an …
Creative Biolabs Identifies Lactobacillus gasseri as a Promising Next-Generation Probiotic
EIN Presswire
·
July 8, 2025
Creative Biolabs has long focused on Lactobacillus gasseri and its potential as a next-generation probiotic for precision microbiota-based therapies. SHIRLEY, NY, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- As part of their research, scientists at …
Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock
GlobeNewswire
·
July 8, 2025
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an …
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
GlobeNewswire
·
July 8, 2025
TORONTO and HAIFA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical results demonstrating that 100% of small animals treated with a …
Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GlobeNewswire
·
July 8, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
GlobeNewswire
·
July 8, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager …
BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025
GlobeNewswire
·
July 8, 2025
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to …
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
GlobeNewswire
·
July 8, 2025
Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2025 …
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
GlobeNewswire
·
July 8, 2025
- SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA - - Solid expects to initiate Phase …
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
GlobeNewswire
·
July 8, 2025
ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced select preliminary …